A. In seeking informed consent from subjects or their representatives, an investigator must provide them with the following elements of information:
1. A statement that the study involves research & an explanation of the purposes of the research;
2. The expected duration of the subject's participation;
3. A description of the procedures to be followed, and identification of any procedures which are experimental;
4. A description of any reasonably foreseeable risks or discomforts to the subjects;
5. A description of any benefits to the subject or to others which may reasonably be expected from the research;
6. A disclosure of appropriate alternative procedures or courses of treatment, if any, that might be advantageous to the subject;
7. A statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained;
8. For research involving more than minimal risk, an explanation as to whether any compensation and whether any medical treatments are available if injury occurs, and if so, what they consist of, or where further information may be obtained;
9. An explanation of whom to contact for information about the research;
10.An explanation of whom to contact for information about research subjects' rights;
11.An explanation of whom to contact in the event of a research related injury.
12.A statement that participation is voluntary, refusal to participate will involve no penalty or loss of benefits to which the subject is otherwise entitled, and the subject may discontinue participation at any time without penalty or loss of benefits to which the subject is otherwise entitled.
B. Whenever appropriate, one or more of the following elements of information must also be provided to the subjects:
1. A statement that the particular treatment or procedure may involve risks to the subject (or to the embryo or fetus, if the subject is or may become pregnant) which are currently unforeseeable;
2. Anticipated circumstances under which the subject's participation may be terminated by the investigator without regard to the subjects' consent;
3. Any additional costs to the subject that may result from participation in the research;
4. The consequences of a subject's decision to withdraw from the research and procedures for orderly termination of participation by the subject;
5. A statement that significant new findings developed during the research which may relate to the subject's willingness to continue participation will be provided to the subject;
6. The approximate number of subjects involved in the study.
Error processing SSI file